Evidence map›Paper›PMID 21689406›Full record

ArticleBMC family practice2011

Health Alliance for prudent antibiotic prescribing in patients with respiratory tract infections (HAPPY AUDIT) -impact of a non-randomised multifaceted intervention programme.

Lars Bjerrum, Anders Munck, Bente Gahrn-Hansen, Malene Plejdrup Hansen, Dorte Ejg Jarbol, Gloria Cordoba, Carl Llor, Josep Maria Cots, Silvia Hernández, Beatriz González López-Valcárcel and 15 more

Open access · goldAbstract read
In one paragraph

Article in BMC family practice, 2011. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 36 papers, 5 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
36citing papers in PubMed, 5 pooled it
5.8field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

36 citing papers in PubMed, 5 syntheses or guidelines pooled it, 64 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Pooled it
  5. Reducing antibiotic prescribing for children with respiratory tract infections in primary care: a systematic review.The British journal of general practice : the journal of the Royal College of General Practitioners · 2013
    Pooled it
  6. Trial
  7. Trial
  8. Article
  9. Article
  10. Article
  11. Review
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Review
  18. [Utilisation of first-line antibiotics six years after a multifaceted intervention].Revista espanola de quimioterapia : publicacion oficial de la Sociedad Espanola de Quimioterapia · 2018
    Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

25 authors at 8 institutions in 6 countries.

Lars BjerrumResearch Unit for General Practice and Section of General Practice, Department of Public Health, University of Copenhagen, Copenhagen, Denmark. lbjerrum@sund.ku.dk
Anders Munck
Bente Gahrn-Hansen
Malene Plejdrup Hansen
Dorte Ejg Jarbol
Gloria Cordoba
Carl Llor
Josep Maria Cots
Silvia Hernández
Beatriz González López-Valcárcel
Antonia Pérez
Lidia Caballero
Walter von der Heyde
Ruta Radzeviciene
Arnoldas Jurgutis
Anatoliy Reutskiy
Elena Egorova
Eva Lena Strandberg
Ingvar Ovhed
Sigvard Mölstad
Robert Vander Stichele
Ria Benko
Vera Vlahovic-Palcevski
Christos Lionis
Marit Rønning
University of Southern Denmark · DKLund University · SESpanish Society of Family and Community Medicine · ESKlaipėda University · LTNational University of Misiones · ARUniversidad de Las Palmas de Gran Canaria · ESUniversity of Copenhagen · DKWorld Organisation of Family Doctors · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundExcessive use of antibiotics is worldwide the most important reason for development of antimicrobial resistance. As antibiotic resistance may spread across borders, high prevalence countries may serve as a source of bacterial resistance for countries with a low prevalence. Therefore, bacterial resistance is an important issue with a potential serious impact on all countries. Initiatives have been taken to improve the quality of antibiotic prescribing in primary care, but only few studies have been designed to determine the effectiveness of multifaceted strategies across countries with different practice setting. The aim of this study was to evaluate the impact of a multifaceted intervention targeting general practitioners (GPs) and patients in six countries with different health organization and different prevalence of antibiotic resistance.

methodsGPs from two Nordic countries, two Baltic Countries and two Hispano-American countries registered patients with respiratory tract infections (RTIs) in 2008 and 2009. After first registration they received individual prescriber feedback and they were offered an intervention programme that included training courses, clinical guidelines, posters for waiting rooms, patient brochures and access to point of care tests (Strep A and C-Reactive Protein). Antibiotic prescribing rates were compared before and after the intervention.

resultsA total of 440 GPs registered 47011 consultations; 24436 before the intervention (2008) and 22575 after the intervention (2009). After the intervention, the GPs significantly reduced the percentage of consultations resulting in an antibiotic prescription. In patients with lower RTI the GPs in Lithuania reduced the prescribing rate by 42%, in Russia by 25%, in Spain by 25%, and in Argentina by 9%. In patients with upper RTIs, the corresponding reductions in the antibiotic prescribing rates were in Lithania 20%, in Russia 15%, in Spain 9%, and in Argentina 5%.

conclusionA multifaceted intervention programme targeting GPs and patients and focusing on improving diagnostic procedures in patients with RTIs may lead to a marked reduction in antibiotic prescribing. The pragmatic before-after design used may suffer from some limitations and the reduction in antibiotic prescribing could be influenced by factors not related to the intervention.

Indexed as

AdolescentAdultAnti-Bacterial AgentsChildDrug PrescriptionsDrug UtilizationFemaleGeneral PracticeHumansMaleProspective StudiesRespiratory Tract InfectionsAnti-Bacterial Agents

Identifiers

PMID21689406
PMCPMC3146837
OpenAlexW2154503433

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.